Top Markets
#1 SSV Network SSV Network +22.92%
#2 EXOD EXOD +22.08%
#3 Derive Derive +21.36%
#4 Velvet Velvet +21.35%
#5 The Black Bull The Black Bull +21.24%
#6 XPIN Network XPIN Network +18.75%
#7 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +18.45%
#8 wojak wojak +18.32%
#9 Bitcoin Cash Bitcoin Cash +18.11%
#10 Arowana Arowana +17.65%
Coin of the day
SSV Network SSV Network
Settings
Language
ENGLISH
Currency
USD
Theme
Xspray Pharma AB (publ) Xspray Pharma AB (publ)

Xspray Pharma AB (publ)

XSPRAY
Rank in Stocks #24929
Xspray Pharma AB (publ), a pharmaceutical firm based in Solna, Sweden,... Xspray Pharma AB (publ), a pharmaceutical firm based in Solna, Sweden, specializes in developing protein kinase inhibitors for precise cancer treatments. Their current drug pipeline includes HyNap-Nilo, aimed at chronic myeloid leukemia; HyNap-Sora, which targets renal, liver, and several types of thyroid cancer; and HyNap-Dasa, intended for both chronic myeloid leukemia and acute lymphoblastic leukemia. Established in 2003, the company was formerly known as Xspray Microparticles AB until its name change to Xspray Pharma AB (publ) in 2017.
Share Price
$1.17
Market Cap
$55.29M
Change (1 day)
0.38%
Change (1 year)
-73.61%
Country
SE
Trade Xspray Pharma AB (publ) (XSPRAY)

Category

Healthcare
Earnings for Xspray Pharma AB (publ) (XSPRAY)
Earnings in 2026 TTM: 0
According to Xspray Pharma AB (publ) latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Xspray Pharma AB (publ) from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US